Tramadol Test Strips
Tramadol is similar to opioid analgesics and is used for the treatment of moderate to severe pain. Like opioids, Tramadol interacts with neurotransmitters in the brain to decrease sensations of pain and induce a sedative affects. Until recently, Tramadol was considered a safer alternative to stronger, highly addictive pain medications such as oxycodone.
As a pain relief medication, Tramadol abuse and dependence is possible with long term or unmonitored use. Standard immunoassay urinalysis tests, such as the SAMHSA-5, do not identify Tramadol and its metabolites in human urine specimens. For that, specific urine test strips are required when Tramadol abuse is suspected.
Tramadol drug test strips are a cost-effective solution to the limitations of tests that only detect opioids such as codeine, morphine, and heroin. With 99% accuracy, 12 Panel Medical urine test strips for Tramadol comply with industry-standards for cutoff concentrations that qualitatively determine Tramadol abuse levels.
Tramadol is also found under the names ConZip, FusePaq Synapryn, Rybix ODT, Ryzolt, Ultram and Ultram ER. These are most commonly prescribed in post-surgical setting and, in some cases, for the treatment of chronic pain. Although not as potent or addictive as other opioids, the FDA has changed its classification of Tramadol due to increasing reports of abuse, misuse, and criminal diversion.
When taken as prescribed, Tramadol is safe and effective. When taken outside of medical supervision, Tramadol use can lead to the development of tolerance, physical dependence, and abuse. Tramadol urine test strips determine whether the drug is at levels consistent with Tramadol abuse and dependence. Urine test strips can identify the parent drug and its metabolites for up to seven days following ingestion.
Similar to opioids, Tramadol is extensively metabolized when administered orally. Only 30% of the drug is eliminated through the urine in its original chemical structure. The remaining 60% is eliminate through human urine in the form of metabolites.
12 Panel Medical urine test strips detect both the parent drug and metabolites in compliance with industry-standard cutoff concentrations. Cutoff concentrations are expressed in nanograms per milliliter and adjusted to 200 ng/ml when testing for Tramadol.
A sample urine specimen must be collected from the donor for testing. When the urine specimen is ready for testing, the operator will remove the Tramadol drug test strip from the protective packaging.
The testing strip may be damaged by extended exposure to light and air. Do not remove the strip until ready to perform the test to ensure the most reliable results. If the testing strip was removed from packaging more than 1 hour prior to testing, the results should not be interpreted.
Do not touch the strip membrane. Bacteria from hands and surfaces may contaminate the testing strip and invalidate results.
Hold the Tramadol drug test strip where the product name is printed. Carefully place the testing strip membrane into the cup, in a vertical position. Do not immerse the strip past the MAX line on the testing strip.
Allow the strip to absorb as much of the sample as possible, immersing the membrane in the specimen for at least 10 to 15 seconds. You might notice color moving across the strip, but the results cannot be read before five minutes. Do not interpret results after 10 minutes.
If the specimen contains more than the pre-determined cutoff levels, the result is positive. This is indicated by one colored band in the control region and no colored band in the test region. Positive results should be sent to a toxicology laboratory for confirmation.
A negative result is indicated by one colored band in the control region, and one colored band in the test region. A negative result indicates that the specimen does not reach the cutoff levels.
If no colored band appears in the control indicator of the test strip, the result is invalid. The test must be performed again. If the problem persists, you may contact your local distributor.